Hospice Of Hope, Llc 15270 West Brookside Lane, Suite 121, Surprise, AZ, 85379 | |
(602) 884-4044 |
News Archive
About two years ago, Dr. Philippe Gros, a McGill University professor in the Department of Biochemistry and a Principal Investigator in thd McGill Life Sciences Complex, described a mouse mutant that was immunodeficient and hypersensitive to the Bacille Calmette-Gu-rin (BCG) vaccine and to tuberculosis (TB).
ImClone Systems Incorporated has announced that it has enrolled the first patient in a disease-directed Phase II clinical trial of IMC-1121B to treat patients with advanced hepatocellular carcinoma (liver cancer).
Researchers have gained a new understanding of the way in which growing tumors are fed and how this growth can be slowed via angiogenesis inhibitors that eliminate the blood supply to tumors. This represents a step forward towards developing new anti-cancer drug therapies.
Purdue University researchers have developed a unique approach that allows experienced surgeons and physicians around the world to help less-experienced doctors in war zones, natural disasters and in rural areas perform complicated procedures.
› Verified 7 days ago
Name | Hospice Of Hope, Llc |
---|---|
Location | 15270 West Brookside Lane, Suite 121, Surprise, Arizona |
Hospice ID | 031655 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Corporation |
Profit Type | FOR PROFIT |
Accreditation Provider | Community Health Accreditation Partner (CHAP) |
SSA county code | 060 |
News Archive
About two years ago, Dr. Philippe Gros, a McGill University professor in the Department of Biochemistry and a Principal Investigator in thd McGill Life Sciences Complex, described a mouse mutant that was immunodeficient and hypersensitive to the Bacille Calmette-Gu-rin (BCG) vaccine and to tuberculosis (TB).
ImClone Systems Incorporated has announced that it has enrolled the first patient in a disease-directed Phase II clinical trial of IMC-1121B to treat patients with advanced hepatocellular carcinoma (liver cancer).
Researchers have gained a new understanding of the way in which growing tumors are fed and how this growth can be slowed via angiogenesis inhibitors that eliminate the blood supply to tumors. This represents a step forward towards developing new anti-cancer drug therapies.
Purdue University researchers have developed a unique approach that allows experienced surgeons and physicians around the world to help less-experienced doctors in war zones, natural disasters and in rural areas perform complicated procedures.
› Verified 7 days ago
NPI Number | 1497263891 |
Organization Name | Hospice Of Hope, Llc |
Address | 15270 W Brookside Ln Ste 121 Surprise, Arizona, 85374 |
Phone Number | (602)884-4044 |
News Archive
About two years ago, Dr. Philippe Gros, a McGill University professor in the Department of Biochemistry and a Principal Investigator in thd McGill Life Sciences Complex, described a mouse mutant that was immunodeficient and hypersensitive to the Bacille Calmette-Gu-rin (BCG) vaccine and to tuberculosis (TB).
ImClone Systems Incorporated has announced that it has enrolled the first patient in a disease-directed Phase II clinical trial of IMC-1121B to treat patients with advanced hepatocellular carcinoma (liver cancer).
Researchers have gained a new understanding of the way in which growing tumors are fed and how this growth can be slowed via angiogenesis inhibitors that eliminate the blood supply to tumors. This represents a step forward towards developing new anti-cancer drug therapies.
Purdue University researchers have developed a unique approach that allows experienced surgeons and physicians around the world to help less-experienced doctors in war zones, natural disasters and in rural areas perform complicated procedures.
› Verified 7 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
About two years ago, Dr. Philippe Gros, a McGill University professor in the Department of Biochemistry and a Principal Investigator in thd McGill Life Sciences Complex, described a mouse mutant that was immunodeficient and hypersensitive to the Bacille Calmette-Gu-rin (BCG) vaccine and to tuberculosis (TB).
ImClone Systems Incorporated has announced that it has enrolled the first patient in a disease-directed Phase II clinical trial of IMC-1121B to treat patients with advanced hepatocellular carcinoma (liver cancer).
Researchers have gained a new understanding of the way in which growing tumors are fed and how this growth can be slowed via angiogenesis inhibitors that eliminate the blood supply to tumors. This represents a step forward towards developing new anti-cancer drug therapies.
Purdue University researchers have developed a unique approach that allows experienced surgeons and physicians around the world to help less-experienced doctors in war zones, natural disasters and in rural areas perform complicated procedures.
› Verified 7 days ago
Home Health Aides | 1 |
Counselors | 1 |
Medical Social Workers | 1 |
Registered Nurses | 1 |
Total Employees | 4 |
---|
News Archive
About two years ago, Dr. Philippe Gros, a McGill University professor in the Department of Biochemistry and a Principal Investigator in thd McGill Life Sciences Complex, described a mouse mutant that was immunodeficient and hypersensitive to the Bacille Calmette-Gu-rin (BCG) vaccine and to tuberculosis (TB).
ImClone Systems Incorporated has announced that it has enrolled the first patient in a disease-directed Phase II clinical trial of IMC-1121B to treat patients with advanced hepatocellular carcinoma (liver cancer).
Researchers have gained a new understanding of the way in which growing tumors are fed and how this growth can be slowed via angiogenesis inhibitors that eliminate the blood supply to tumors. This represents a step forward towards developing new anti-cancer drug therapies.
Purdue University researchers have developed a unique approach that allows experienced surgeons and physicians around the world to help less-experienced doctors in war zones, natural disasters and in rural areas perform complicated procedures.
› Verified 7 days ago
Others | 0.25 |
Total Volunteers | 0.25 |
---|
News Archive
About two years ago, Dr. Philippe Gros, a McGill University professor in the Department of Biochemistry and a Principal Investigator in thd McGill Life Sciences Complex, described a mouse mutant that was immunodeficient and hypersensitive to the Bacille Calmette-Gu-rin (BCG) vaccine and to tuberculosis (TB).
ImClone Systems Incorporated has announced that it has enrolled the first patient in a disease-directed Phase II clinical trial of IMC-1121B to treat patients with advanced hepatocellular carcinoma (liver cancer).
Researchers have gained a new understanding of the way in which growing tumors are fed and how this growth can be slowed via angiogenesis inhibitors that eliminate the blood supply to tumors. This represents a step forward towards developing new anti-cancer drug therapies.
Purdue University researchers have developed a unique approach that allows experienced surgeons and physicians around the world to help less-experienced doctors in war zones, natural disasters and in rural areas perform complicated procedures.
› Verified 7 days ago
Hospice Promise, Llc Location: 12213 West Bell Road, Suite 115, Surprise, Arizona, 85378 Phone: (602) 884-4044 |
Hospice Of Hope, Llc Location: 15270 West Brookside Lane, Suite 121, Surprise, Arizona, 85379 Phone: (602) 884-4044 |